Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study
Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study
Authors of this article:
Jussi Seppälä1, 2
;
Eva Grasa3, 4
;
Anna Alonso-Solis4, 5
;
Alexandra Roldan-Bejarano3, 4
;
Marianne Haapea2, 6, 7
;
Matti Isohanni2
;
Jouko Miettunen2, 6
;
Johanna Caro Mendivelso8
;
Cari Almazán8
;
Katya Rubinstein9
;
Asaf Caspi9
;
Zolt Unoka10
;
Kinga Farkas10
;
Elisenda Reixach11
;
Jesus Berdun12
;
Judith Usall4, 13, 14
;
Susana Ochoa4, 13, 14
;
Iluminada Corripio4, 15, 16
;
Erika Jääskeläinen17
;
m-Resist Group
There are no citations yet available for this article according to
Crossref
.